3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Stomatitis
3
Uterine Cervical Neoplasms
2
Skin Neoplasms
2
Laryngeal Neoplasms
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Dyspareunia
2
Carcinoma, Hepatocellular
2
Carcinoma, Basal Cell
2
Breast Neoplasms
2
Warts
1
Vulvar Neoplasms
1
Vomiting
1
Vaginal Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Squamous Intraepithelial Lesions
1
Squamous Cell Carcinoma of Head and Neck
1
Soft Tissue Neoplasms
1
Retinoblastoma
1
Radiodermatitis
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Papilloma
1
Pain
1
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Interventions
Dexamethasone
36
Aprepitant
31
Palonosetron
27
Ondansetron
23
Granisetron
14
fosaprepitant
13
Calcium Dobesilate
12
Olanzapine
11
Therapeutics
7
ramosetron
6
dexamethasone acetate
5
Tropisetron
5
Doxorubicin
5
Cyclophosphamide
5
Surveys and Questionnaires
4
Metoclopramide
4
netupitant, palosentron drug combination
3
netupitant
3
dolasetron
3
dexamethasone 21-phosphate
3
Yoga
3
Vincristine
3
Psychiatric Rehabilitation
3
Prochlorperazine
3
Lorazepam
3
Dronabinol
3
Diphenhydramine
3
Acupressure
3
ginger extract
2
Thalidomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Vomiting
×
Laser Therapy
×
Clear all
NCT03354741
2026-03-27
NAUVOLA
Centre Hospitalier Universitaire de Nice
Phase NA
Completed
30 enrolled